Jinnai Nobuyoshi, Sakagami Takuro, Sekigawa Takashi, Kakihara Miho, Nakajima Toshiaki, Yoshida Kenichi, Goto Shin, Hasegawa Takashi, Koshino Takeshi, Hasegawa Yoshinori, Inoue Hiromasa, Suzuki Naohito, Sano Yasuyuki, Inoue Ituro
Division of Genetic Diagnosis, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Hum Mol Genet. 2004 Dec 15;13(24):3203-17. doi: 10.1093/hmg/ddh332. Epub 2004 Oct 20.
Aspirin-intolerant asthma (AIA) is a subtype of bronchial asthma characterized by development of bronchoconstriction evoked by non-steroidal anti-inflammatory drugs (NSAIDs). NSAIDs inhibit the cyclooxygenase pathway, leading to enhancement of the lipoxygenase pathway. We evaluated allelic association of 370 single nucleotide polymorphisms (SNPs) of 63 candidate genes, mostly from the arachidonic acid metabolic cascade, with AIA. After two rounds of screening with 198 AIA patients, multiple SNPs in the prostaglandin E(2) receptor subtype 2 (EP2) gene were associated with AIA (P<0.05). Among the 77 SNPs identified in the EP2 gene, we selected 17 SNPs on the basis of linkage disequilibrium and allelic frequencies (minor allele frequency >0.1) for further association study. SNPs in the promoter region of the EP2 gene, uS5, uS5b, and uS7, were significantly associated with AIA (permutation P=0.039-0.001). Analysis of haplotypes constructed according to the LD pattern showed a significant association with AIA (permutation P=0.001). The most significantly associated SNP, uS5, located in the regulatory region of the EP2 gene, was in a STATs-binding consensus sequence [AIA 31.1% versus control 22.1% (permutation P=0.0016) or versus aspirin-tolerant asthma 22.2% (permutation P=0.0017)]. Although STAT1 binding was not observed in gel mobility shift assay with HeLa nuclear extract, an unidentified protein was specifically bound to the allelic sequence. In in vitro reporter assay in HCT116 cells, the site containing the uS5 allele showed reduced transcription activity. Taken together, these results suggest that uS5 allele serves as a target of a transcription repressor protein. A functional SNP of the EP2 gene associated with risk of AIA should decrease the transcription level, resulting in reduction of the PGE(2) braking mechanism of inflammation and involvement in the molecular mechanism underlying AIA.
阿司匹林不耐受性哮喘(AIA)是支气管哮喘的一种亚型,其特征为非甾体抗炎药(NSAIDs)诱发支气管收缩。NSAIDs抑制环氧化酶途径,导致脂氧合酶途径增强。我们评估了63个候选基因(大多来自花生四烯酸代谢级联反应)的370个单核苷酸多态性(SNP)与AIA的等位基因关联。在用198例AIA患者进行两轮筛选后,前列腺素E(2)受体2型(EP2)基因中的多个SNP与AIA相关(P<0.05)。在EP2基因中鉴定出的77个SNP中,我们基于连锁不平衡和等位基因频率(次要等位基因频率>0.1)选择了17个SNP进行进一步的关联研究。EP2基因启动子区域的SNP,即uS5、uS5b和uS7,与AIA显著相关(置换P=0.039-0.001)。根据连锁不平衡模式构建的单倍型分析显示与AIA显著相关(置换P=0.001)。最显著相关的SNP,即位于EP2基因调控区域的uS5,存在于STATs结合共有序列中[AIA为31.1%,对照为22.1%(置换P=0.0016)或与阿司匹林耐受哮喘相比为22.2%(置换P=0.0017)]。尽管在使用HeLa细胞核提取物的凝胶迁移率变动分析中未观察到STAT1结合,但一种未鉴定的蛋白质特异性结合至等位基因序列。在HCT116细胞的体外报告基因分析中,含有uS5等位基因的位点显示转录活性降低。综上所述,这些结果表明uS5等位基因是转录抑制蛋白的作用靶点。与AIA风险相关的EP2基因功能性SNP应会降低转录水平,导致炎症的PGE(2)制动机制减弱,并参与AIA潜在的分子机制。